These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30443716)

  • 41. Vaccines against human papillomavirus infections: protection against cancer, genital warts or both?
    Joura EA; Pils S
    Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S125-S127. PubMed ID: 28034371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genital Wart and Human Papillomavirus Prevalence in Men in the United States From Penile Swabs: Results From National Health and Nutrition Examination Surveys.
    Daugherty M; Byler T
    Sex Transm Dis; 2018 Jun; 45(6):412-416. PubMed ID: 29750774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human Pappilomavirus (HPV) induced cancers and prevention by immunization.
    Khaliq SA; Shyum Naqvi SB; Fatima A
    Pak J Pharm Sci; 2012 Oct; 25(4):763-72. PubMed ID: 23009992
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiology of human papillomavirus infections.
    Beutner KR; Becker TM; Stone KM
    Dermatol Clin; 1991 Apr; 9(2):211-8. PubMed ID: 1647901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.
    Woestenberg PJ; King AJ; van der Sande MA; Donken R; Leussink S; van der Klis FR; Hoebe CJ; Bogaards JA; van Benthem BH; ;
    J Infect; 2017 Apr; 74(4):393-400. PubMed ID: 28126492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Promising control of genital warts: but is elimination possible?
    Lacey CJ; Garnett GP
    Lancet Infect Dis; 2011 Jan; 11(1):4-6. PubMed ID: 21183139
    [No Abstract]   [Full Text] [Related]  

  • 47. Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK.
    Datta S; Pink J; Medley GF; Petrou S; Staniszewska S; Underwood M; Sonnenberg P; Keeling MJ
    BMC Infect Dis; 2019 Jun; 19(1):552. PubMed ID: 31234784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Impact of Human Papillomavirus Catch-Up Vaccination in Australia: Implications for Introduction of Multiple Age Cohort Vaccination and Postvaccination Data Interpretation.
    Drolet M; Laprise JF; Brotherton JML; Donovan B; Fairley CK; Ali H; Bénard É; Martin D; Brisson M
    J Infect Dis; 2017 Dec; 216(10):1205-1209. PubMed ID: 28968800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The incidence of genital warts in Australian women prior to the national vaccination program.
    Brotherton JM; Heywood A; Heley S
    Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genitoanal human papillomavirus infection and associated neoplasias.
    Gross G
    Curr Probl Dermatol; 2014; 45():98-122. PubMed ID: 24643181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human papillomavirus infection with particular reference to genital disease.
    Sonnex C
    J Clin Pathol; 1998 Sep; 51(9):643-8. PubMed ID: 9930065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HPV: diagnosis, prevention, and treatment.
    Hathaway JK
    Clin Obstet Gynecol; 2012 Sep; 55(3):671-80. PubMed ID: 22828099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma: a phase I/II study.
    Albarran Y Carvajal A; de la Garza A; Cruz Quiroz BJ; Vazquez Zea E; Díaz Estrada I; Mendez Fuentez E; López Contreras M; Andrade-Manzano A; Padilla S; Varela AR; Rosales R
    BioDrugs; 2007; 21(1):47-59. PubMed ID: 17263589
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HPV vaccine promotion: does referring to both cervical cancer and genital warts affect intended and actual vaccination behavior?
    Juraskova I; Bari RA; O'Brien MT; McCaffery KJ
    Womens Health Issues; 2011; 21(1):71-9. PubMed ID: 21185992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Correlation of human papillomavirus (HPV) and HPV vaccines with male reproductive health].
    Yu YB; Ren YZ; Niu HT
    Zhonghua Nan Ke Xue; 2019 Aug; 25(8):749-753. PubMed ID: 32227721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention strategies against the human papillomavirus: the effectiveness of vaccination.
    Stanley M
    Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S19-23. PubMed ID: 17938013
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How to best measure the effectiveness of male human papillomavirus vaccine programmes?
    Garland SM; Molesworth EG; Machalek DA; Cornall AM; Tabrizi SN
    Clin Microbiol Infect; 2015 Sep; 21(9):834-41. PubMed ID: 26055415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Condyloma typing important for follow up of HPV vaccination. A condyloma reporting project].
    Sturegård E; Johnsson A; Gustafsson E; Dillner J
    Lakartidningen; 2008 Dec 10-16; 105(50):3648-50. PubMed ID: 19177930
    [No Abstract]   [Full Text] [Related]  

  • 59. [Human papillomavirus disease burden in men : HPV prevention is a man's business].
    Schneede P
    Urologe A; 2018 Dec; 57(12):1452-1456. PubMed ID: 30194470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genital human papillomavirus infection in men.
    Partridge JM; Koutsky LA
    Lancet Infect Dis; 2006 Jan; 6(1):21-31. PubMed ID: 16377531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.